• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

相似文献

1
Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: an observational study on outcome and microcirculatory changes.恶性胸膜间皮瘤扩大胸膜切除术和纤维板剥脱术后的胸腔内热化疗:一项关于结局和微循环变化的观察性研究
J Thorac Dis. 2018 Jan;10(Suppl 2):S228-S236. doi: 10.21037/jtd.2018.01.10.
2
Pleurectomy/decortication and hyperthermic intrathoracic chemoperfusion using cisplatin and doxorubicin for malignant pleural mesothelioma.胸膜切除术/纤维板剥脱术及使用顺铂和阿霉素进行胸腔内热灌注化疗治疗恶性胸膜间皮瘤
J Thorac Dis. 2019 May;11(5):1963-1972. doi: 10.21037/jtd.2019.04.93.
3
Induction Chemotherapy Followed by Pleurectomy Decortication and Hyperthermic Intraoperative Chemotherapy (HITHOC) for Early-Stage Epitheliod Malignant Pleural Mesothelioma-A Prospective Report.诱导化疗后行胸膜剥脱术及术中热灌注化疗(HITHOC)治疗早期上皮样恶性胸膜间皮瘤——一项前瞻性报告
J Clin Med. 2021 Nov 26;10(23):5542. doi: 10.3390/jcm10235542.
4
Recruitment of sublingual microcirculation using handheld incident dark field imaging as a routine measurement tool during the postoperative de-escalation phase-a pilot study in post ICU cardiac surgery patients.在术后降阶梯治疗阶段,使用手持式入射式暗视野成像作为常规测量工具对舌下微循环进行评估——一项针对重症监护病房后心脏手术患者的初步研究
Perioper Med (Lond). 2018 Aug 9;7:18. doi: 10.1186/s13741-018-0091-x. eCollection 2018.
5
Pleurectomy/decortication and hyperthermic intrapleural chemotherapy for malignant pleural mesothelioma: initial experience.胸膜切除术/去皮质术及热灌注胸腔内化疗治疗恶性胸膜间皮瘤:初步经验
Future Oncol. 2015;11(24 Suppl):19-22. doi: 10.2217/fon.15.286.
6
Hyperthermic Intrathoracic Chemotherapy (HITHOC) for Pleural Malignancies-Experience from Indian Centers.用于胸膜恶性肿瘤的胸腔内热化疗(HITHOC)——来自印度中心的经验。
Indian J Surg Oncol. 2019 Feb;10(Suppl 1):91-98. doi: 10.1007/s13193-018-0859-y. Epub 2018 Dec 11.
7
Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study.电视辅助胸膜切除术/纤维板剥脱术联合胸腔内热化疗与电视辅助胸腔镜滑石粉胸膜固定术治疗恶性胸膜间皮瘤的比较:一项前瞻性研究。
Heliyon. 2023 May 25;9(6):e16685. doi: 10.1016/j.heliyon.2023.e16685. eCollection 2023 Jun.
8
Effect of hyperthermic intrathoracic chemotherapy on the malignant pleural mesothelioma: a systematic review and meta-analysis.胸腔内热化疗对恶性胸膜间皮瘤的影响:一项系统评价和荟萃分析。
Oncotarget. 2017 Oct 19;8(59):100640-100647. doi: 10.18632/oncotarget.22062. eCollection 2017 Nov 21.
9
Microcirculatory changes in children undergoing cardiac surgery: a prospective observational study.小儿心脏手术中的微循环变化:一项前瞻性观察研究。
Br J Anaesth. 2016 Aug;117(2):206-13. doi: 10.1093/bja/aew187.
10
Microcirculatory blood flow during cardiac arrest and cardiopulmonary resuscitation does not correlate with global hemodynamics: an experimental study.心脏骤停和心肺复苏期间的微循环血流与整体血流动力学不相关:一项实验研究。
J Transl Med. 2016 Jun 8;14(1):163. doi: 10.1186/s12967-016-0934-5.

引用本文的文献

1
The Role of Hyperthermic Intrathoracic Chemotherapy (HITHOC) in Thoracic Tumors.胸腔内热化疗(HITHOC)在胸部肿瘤中的作用。
Cancers (Basel). 2024 Jul 11;16(14):2513. doi: 10.3390/cancers16142513.

本文引用的文献

1
National Trends in the Epidemiology of Malignant Pleural Mesothelioma: A National Cancer Data Base Study.国家恶性胸膜间皮瘤的流行病学趋势:国家癌症数据库研究。
Ann Thorac Surg. 2018 Feb;105(2):432-437. doi: 10.1016/j.athoracsur.2017.09.036. Epub 2017 Dec 7.
2
Diaphragm and lung-preserving surgery with hyperthermic chemotherapy for malignant pleural mesothelioma: A 10-year experience.恶性胸膜间皮瘤的高热化疗保肺膈胸膜切除术:10 年经验。
J Thorac Cardiovasc Surg. 2018 Apr;155(4):1857-1866.e2. doi: 10.1016/j.jtcvs.2017.10.070. Epub 2017 Nov 1.
3
Association of Fluid Administration With Morbidity in Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy.细胞减灭术联合腹腔热灌注化疗中液体输注与发病率的关系
JAMA Surg. 2017 Dec 1;152(12):1156-1160. doi: 10.1001/jamasurg.2017.2865.
4
The Pressure Recording Analytical Method (PRAM): Technical Concepts and Literature Review.压力记录分析法(PRAM):技术概念与文献综述
J Cardiothorac Vasc Anesth. 2017 Aug;31(4):1460-1470. doi: 10.1053/j.jvca.2016.09.004. Epub 2016 Sep 14.
5
Microcirculatory changes in children undergoing cardiac surgery: a prospective observational study.小儿心脏手术中的微循环变化:一项前瞻性观察研究。
Br J Anaesth. 2016 Aug;117(2):206-13. doi: 10.1093/bja/aew187.
6
The management of the diaphragm during radical surgery for malignant pleural mesothelioma.恶性胸膜间皮瘤根治性手术中膈肌的处理
Eur J Cardiothorac Surg. 2016 Aug;50(2):311-6. doi: 10.1093/ejcts/ezw045. Epub 2016 Mar 22.
7
Cytoreductive surgery and hyperthermic intraperitoneal chemotherapy: a review of factors contributing to morbidity and mortality.肿瘤细胞减灭术及腹腔热灌注化疗:对发病和死亡相关因素的综述
J Gastrointest Oncol. 2016 Feb;7(1):99-111. doi: 10.3978/j.issn.2078-6891.2015.100.
8
Anaesthetic management of cytoreductive surgery followed by hyperthermic intrathoracic chemotherapy perfusion.减瘤手术后胸腔内热化疗灌注的麻醉管理。
J Cardiothorac Surg. 2014 Jul 25;9:125. doi: 10.1186/1749-8090-9-125.
9
Hyperthermic intraoperative pleural cisplatin chemotherapy extends interval to recurrence and survival among low-risk patients with malignant pleural mesothelioma undergoing surgical macroscopic complete resection.高热术中胸膜顺铂化疗延长了低危恶性胸膜间皮瘤患者接受手术宏观完全切除术后的复发和生存间隔。
J Thorac Cardiovasc Surg. 2013 Apr;145(4):955-963. doi: 10.1016/j.jtcvs.2012.12.037. Epub 2013 Feb 21.
10
The role of surgical cytoreduction in the treatment of malignant pleural mesothelioma: meeting summary of the International Mesothelioma Interest Group Congress, September 11-14, 2012, Boston, Mass.手术细胞减灭术在恶性胸膜间皮瘤治疗中的作用:2012年9月11日至14日于马萨诸塞州波士顿召开的国际间皮瘤兴趣小组大会会议总结
J Thorac Cardiovasc Surg. 2013 Apr;145(4):909-910. doi: 10.1016/j.jtcvs.2013.01.039. Epub 2013 Feb 14.

恶性胸膜间皮瘤扩大胸膜切除术和纤维板剥脱术后的胸腔内热化疗:一项关于结局和微循环变化的观察性研究

Hyperthermic intrathoracic chemotherapy after extended pleurectomy and decortication for malignant pleura mesothelioma: an observational study on outcome and microcirculatory changes.

作者信息

Luzzi Luca, Franchi Federico, Dapoto Annarita, Ghisalberti Marco, Corzani Roberto, Marrelli Daniele, Marchetti Luca, Paladini Piero, Scolletta Sabino

机构信息

Thoracic Surgery Unit, Department of Medicine, Surgery and Neuroscences, Siena University Hospital Siena, Italy.

Unit of Anesthesia and Critical Care Medicine, Department of Medical Biotechnologies, Siena University Hospital, Siena, Italy.

出版信息

J Thorac Dis. 2018 Jan;10(Suppl 2):S228-S236. doi: 10.21037/jtd.2018.01.10.

DOI:10.21037/jtd.2018.01.10
PMID:29507790
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC5830558/
Abstract

BACKGROUND

In the treatment of malignant pleural mesothelioma the Hyperthermic Intra THOracic Chemotherapy (HITHOC) can improve the efficacy of pleurectomy and decortication with a local cytotoxic effect. However its biological impact in patient's hemodynamic and microcirculatory changes were rarely investigated. Aim of this study is to describe our experience with HITHOC after pleurectomy and decortication evaluating the role of sublingual video-microscopy in assessing the microcirculatory changes in the perioperative period.

METHODS

This is a prospective and observational study concerning 10 consecutive patients undergoing extended P/D followed by HITHOC. These patients underwent sublingual microcirculatory monitoring, which was adopted as a routine procedure since 2012. Haemodynamic parameters were collected at eight consecutive times: the day before surgery (T1), induction of anaesthesia (T2), surgical phase before HITHOC beginning (T3), 5 and 30 minutes after HITHOC start (T4 and T5, respectively), 5 minutes from HITHOC end (T6), after the admission in ICU (T7), at discharge from the ICU (T8). Cardiac output (CO) was calculated with MostCare. Systemic vascular resistance (SVR), oxygen delivery (DO), and oxygen extraction rate (OER) were calculated using standard formulas. Arterial blood pressure and central venous pressure (CVP) were obtained with standard arterial and venous catheters. At the same times we assessed the sublingual microcirculation with Sidestream Dark Field technique.

RESULTS

Hemodynamic and microcirculatory data were collected in 10 patients, 8 male and 2 females (mean age 68.6±9.0, and body surface area of 1.9±0.1 m). All patients had arterial hypertension, and one patient had diabetes. The mean arterial pressure significantly decreased at T2, with respect to T1 (P=0.05). CO, CVP, DO, OER, and ScvO, did not change significantly over the time. All patients needed infusion of noradrenalin from T4 to T6. TVD significantly decreased from T1 to T3, T5, and T8. Similarly, PVD significantly decreased from T1 to T3 and T8, and MFI from T1 to T6 and T8. PPV and HI did not change over the study period. No correlation was found between hemodynamic parameters (MAP, CO, CVP, DO, OER, ScvO) and microcirculatory data (TVD, PVD, PPV, MFI, HI), at any time of the study.

CONCLUSIONS

In patients who receive HITHOC the fluid load can reduce the microvascular impairment restoring the normal tissue perfusion. This process takes days but is most evident in the first 72 h. The use of colloid and blood transfusion is much more effective in restoring microcirculation and reducing tissue damaging.

摘要

背景

在恶性胸膜间皮瘤的治疗中,胸腔内热化疗(HITHOC)可通过局部细胞毒性作用提高胸膜切除术和去皮质术的疗效。然而,其对患者血流动力学和微循环变化的生物学影响鲜有研究。本研究的目的是描述我们在胸膜切除术和去皮质术后进行HITHOC的经验,评估舌下视频显微镜在评估围手术期微循环变化中的作用。

方法

这是一项前瞻性观察性研究,涉及10例连续接受扩大胸膜切除术和去皮质术并随后进行HITHOC的患者。自2012年以来,这些患者接受了舌下微循环监测,并将其作为常规程序。连续八次收集血流动力学参数:手术前一天(T1)、麻醉诱导时(T2)、HITHOC开始前的手术阶段(T3)、HITHOC开始后5分钟和30分钟(分别为T4和T5)、HITHOC结束后5分钟(T6)、入住重症监护病房后(T7)、从重症监护病房出院时(T8)。心输出量(CO)用MostCare计算。全身血管阻力(SVR)、氧输送(DO)和氧摄取率(OER)使用标准公式计算。通过标准动脉和静脉导管获得动脉血压和中心静脉压(CVP)。同时,我们使用侧流暗视野技术评估舌下微循环。

结果

收集了10例患者的血流动力学和微循环数据,其中8例男性,2例女性(平均年龄68.6±9.0岁,体表面积1.9±0.1平方米)。所有患者均患有动脉高血压,1例患者患有糖尿病。与T1相比,T2时平均动脉压显著降低(P = 0.05)。CO、CVP、DO、OER和ScvO₂随时间无显著变化。所有患者从T4到T6都需要输注去甲肾上腺素。TVD从T1到T3、T5和T8显著降低。同样,PVD从T1到T3和T8显著降低,MFI从T1到T6和T8显著降低。在研究期间,PPV和HI没有变化。在研究的任何时间,血流动力学参数(MAP、CO、CVP、DO、OER、ScvO₂)与微循环数据(TVD、PVD、PPV、MFI、HI)之间均未发现相关性。

结论

在接受HITHOC的患者中,液体负荷可减轻微血管损伤,恢复正常组织灌注。这个过程需要数天,但在最初72小时最为明显。使用胶体和输血在恢复微循环和减少组织损伤方面更有效。